Genprex, Inc. (GNPX)
3.425
-0.08
(-2.42%)
USD |
NASDAQ |
Sep 03, 16:00
3.52
+0.10
(+2.77%)
After-Hours: 06:56
Genprex Market Cap : 1.734M for Sept. 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 03, 2026 | 1.734M |
| September 02, 2026 | 1.777M |
| September 01, 2026 | 1.797M |
| August 31, 2026 | 1.878M |
| August 28, 2026 | 1.858M |
| August 27, 2026 | 1.827M |
| August 26, 2026 | 2.010M |
| August 25, 2026 | 2.025M |
| August 24, 2026 | 2.035M |
| August 21, 2026 | 2.000M |
| August 20, 2026 | 2.000M |
| August 19, 2026 | 2.020M |
| August 18, 2026 | 2.000M |
| August 17, 2026 | 2.265M |
| August 14, 2026 | 2.187M |
| August 13, 2026 | 2.465M |
| August 12, 2026 | 2.394M |
| August 11, 2026 | 2.263M |
| August 10, 2026 | 1.722M |
| August 07, 2026 | 1.755M |
| August 06, 2026 | 1.825M |
| August 05, 2026 | 1.825M |
| August 04, 2026 | 1.817M |
| August 03, 2026 | 1.953M |
| July 31, 2026 | 2.462M |
| Date | Value |
|---|---|
| July 30, 2026 | 2.491M |
| July 29, 2026 | 2.927M |
| July 28, 2026 | 3.301M |
| July 27, 2026 | 3.180M |
| July 24, 2026 | 3.211M |
| July 23, 2026 | 3.079M |
| July 22, 2026 | 3.457M |
| July 21, 2026 | 3.291M |
| July 20, 2026 | 2.964M |
| July 17, 2026 | 3.153M |
| July 16, 2026 | 3.289M |
| July 15, 2026 | 4.440M |
| July 14, 2026 | 4.189M |
| July 13, 2026 | 4.840M |
| July 10, 2026 | 111.41M |
| July 09, 2026 | 110.54M |
| July 08, 2026 | 112.21M |
| July 07, 2026 | 117.60M |
| July 06, 2026 | 123.57M |
| July 02, 2026 | 114.62M |
| July 01, 2026 | 106.32M |
| June 30, 2026 | 103.27M |
| June 29, 2026 | 100.49M |
| June 26, 2026 | 98.46M |
| June 25, 2026 | 93.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.796B |
| Alnylam Pharmaceuticals, Inc. | 35.37B |
| Anika Therapeutics, Inc. | 281.04M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.071B |
Market Cap Related Metrics
| Price to Book Value | 0.1172 |
| Price | 3.425 |
| Earnings Yield | -4.64K% |